Triglav Investments D.O.O. Makes New Investment in HCA Healthcare, Inc. $HCA

Triglav Investments D.O.O. purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,000 shares of the company’s stock, valued at approximately $852,000.

A number of other large investors have also made changes to their positions in the stock. Sovran Advisors LLC lifted its position in HCA Healthcare by 1.0% during the third quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock worth $1,063,000 after buying an additional 22 shares in the last quarter. Hemington Wealth Management boosted its position in shares of HCA Healthcare by 11.0% during the 3rd quarter. Hemington Wealth Management now owns 253 shares of the company’s stock valued at $107,000 after acquiring an additional 25 shares during the last quarter. Abound Wealth Management raised its stake in HCA Healthcare by 28.0% during the third quarter. Abound Wealth Management now owns 119 shares of the company’s stock worth $51,000 after purchasing an additional 26 shares during the period. Annis Gardner Whiting Capital Advisors LLC increased its holdings in shares of HCA Healthcare by 17.1% during the 3rd quarter. Annis Gardner Whiting Capital Advisors LLC now owns 185 shares of the company’s stock worth $79,000 after buying an additional 27 shares during the last quarter. Finally, Ballentine Partners LLC grew its position in HCA Healthcare by 0.8% in the third quarter. Ballentine Partners LLC now owns 3,693 shares of the company’s stock worth $1,574,000 after acquiring an additional 29 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Trading Down 1.2%

Shares of NYSE HCA opened at $493.09 on Thursday. HCA Healthcare, Inc. has a 12-month low of $295.00 and a 12-month high of $527.55. The stock has a market cap of $112.52 billion, a P/E ratio of 17.37, a PEG ratio of 1.53 and a beta of 1.36. The business’s fifty day simple moving average is $480.20 and its 200-day simple moving average is $440.62.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same quarter last year, the company earned $6.22 EPS. HCA Healthcare’s revenue for the quarter was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 10.99%.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on HCA shares. TD Cowen reiterated a “buy” rating on shares of HCA Healthcare in a report on Wednesday, January 28th. Cantor Fitzgerald lifted their price target on shares of HCA Healthcare from $525.00 to $588.00 and gave the company an “overweight” rating in a research report on Wednesday, January 28th. The Goldman Sachs Group increased their price objective on shares of HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Barclays upped their price target on HCA Healthcare from $494.00 to $551.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 28th. Finally, Sanford C. Bernstein reiterated a “market perform” rating on shares of HCA Healthcare in a report on Wednesday, January 28th. Fifteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $519.71.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.